New York, NY
,
USA
·
Global
OrbiMed is a New York-based investment firm specialising exclusively in healthcare and life sciences, with over $20 billion in assets under management across public and private strategies. The firm backs Series A through pre-IPO companies in biopharmaceuticals, medical devices, and digital health, typically investing $10M–$100M. Notable portfolio companies span oncology, rare disease, and immunology.
Know when they open it, which slides they read, and when to follow up.
Pitchwise turns every shared deck into a live intelligence feed.
